7 results
Bell's Palsy - Diagnosis and Management Summary - GrepMed Handbook

Acute Idiopathic Unilateral Facial Nerve (CN7) Palsy
Presentation:
Bell's Palsy - Diagnosis ... and Management ... ophthalmoplegia), systemic signs ... within 4m #Bells ... #Treatment #Neurology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... B-LNH), solid cancers ... Nicolas Taar ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
Amyotrophic Lateral Sclerosis (ALS) Summary
ALS: combination of the clinical examination finding of amyotrophy with the pathologic
lateral sclerosis Pathophysiology ... of UMN and LMN signs ... diagnosis column Treatment ... Lateral #Sclerosis #neurology ... #diagnosis #management
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
person-years • 50-year ... Symptoms and Signs ... common symptoms and signs ... procedures (eg, colonoscopy ... Beta blockers cancel
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... • Bilateral signs ... Transverse Myelitis Treatment ... Myelitis #diagnosis #management ... #neurology #differential
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis infections/year ... tuberculosis (LTBI) Pathophysiology ... Lymphoma • Lung cancer ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis infections/year ... tuberculosis (LTBI) Pathophysiology ... Lymphoma • Lung cancer ... TB #Diagnosis #Management ... #Treatment #ActiveTB